SCHEMBL16310135

SCHEMBL16310135

CCOC(=O)C(Cc1c[nH]cn1)NC=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 4/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TP53 P04637 5/20 0.32
▸ TSHR P16473 3/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ JAK2 O60674 2/20 0.32
▸ JAK3 P52333 2/20 0.32
▸ ELANE P08246 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ LMNA P02545 2/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16310139 0.89 HDAC6 (0.34) NLRP3TSHR
SCHEMBL19123170 0.85 SMN1; SMN2 (0.35) NLRP3SMN1; SMN2TP53TSHRCYP1A2
SCHEMBL3337001 0.85 SMN1; SMN2 (0.35) NLRP3SMN1; SMN2TP53TSHRCYP1A2
SCHEMBL13246853 0.85 SMN1; SMN2 (0.35) NLRP3SMN1; SMN2TP53TSHRCYP1A2
Hydrochloric Acid SCHEMBL3339489 0.84 SMN1; SMN2 (0.34) NLRP3SMN1; SMN2TP53TSHRCYP1A2
SCHEMBL13267843 0.84 SMN1; SMN2 (0.39) NLRP3SMN1; SMN2CYP1A2CYP2C9HIF1A
SCHEMBL5810644 0.83 TACR1 (0.39) NLRP3SMN1; SMN2TP53MAPTLMNA
SCHEMBL5810645 0.83 TACR1 (0.39) NLRP3SMN1; SMN2TP53MAPTLMNA
SCHEMBL61919 0.82 CPB2 (0.32) —
SCHEMBL61920 0.82 CPB2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912185-B2 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents Obschestvo S Ogranichennoi Otvetstvennostyu “Pharmenterprises” (RU) 2014-12-16 — — US disclosed
Send feedback